An alternative methodology for the prediction of adherence to anti HIV treatment

AIDS Research and Therapy

Volumn 6, Issue , 2009, Pages

  Thomson, I Richard ^a   Bidgood, Penelope ^a   Petróczi, Andrea ^a   Denholm Price, James C W ^a   Fielder, Mark D ^a  

^a KINGSTON UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ANTIVIRAL THERAPY; ARTICLE; CLINICAL PRACTICE; GENE SEQUENCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METHODOLOGY; PATIENT COMPLIANCE; PREDICTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; VALIDATION STUDY; VIRUS GENOME; VIRUS LOAD; VIRUS MUTATION;

EID: 67749140112     PISSN: 17426405     EISSN: None     Source Type: Journal    
DOI: 10.1186/1742-6405-6-9     Document Type: Article

References (41)

1. Hymes KB Cheung T Greene JB Prose NS Marcus A Ballard H William DC Laubenstein LJ Kaposi's sarcoma in homosexual men-a report of eight cases Lancet 1981, 2:598-600 6116083
2. Centers for Disease Control (CDC) Pneumocystis pneumonia - Los Angeles MMWR Morb Mortal Wkly Rep. 1981, 30(21):250-252 6265753
3. Thomsen HK Jacobsen M Malchow-Moller A Kaposi sarcoma among homosexual men in Europe Lancet 1981, 2:688 6116060
4. Landesman SH Ginzburg HM Weiss SH The AIDS epidemic N Engl J Med 1985, 312:521-525 2982097
5. Gao F Bailes E Robertson DL Chen Y Rodenburg CM Michael SF Cummins LB Arthur LO Peeters M Shaw GM Sharp PM Hahn BH Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes Nature 1999, 397:436-441 9989410
6. UNAIDS AIDS epidemic update 07 2008
7. Centers for Disease Control (CDC) Acquired Immunodeficiency Syndrome (AIDS) weekly surveillance report- United States 1983
8. Curran JW Jaffe HW Hardy AM Morgan WM Selik RM Dondero TJ Epidemiology of HIV infection and AIDS in the United States Science 1988, 239:610-616 3340847
9. Antiretroviral Therapy Cohort Collaboration Life expectancy of individuals on combination antiretroviral therapy in high-income countries: A collaborative analysis of 14 cohort studies Lancet 2008, 372:293-299 18657708
10. Lucas GM Antiretroviral adherence, drug resistance, viral fitness and HIV disease progression: A tangled web is woven J Antimicrob Chemother 2005, 55:413-416 15722389
11. Bangsberg DR Charlebois ED Grant RM Holodniy M Deeks SG Perry S Conroy KN Clark R Guzman D Zolopa A Moss A High levels of adherence do not prevent accumulation of HIV drug resistance mutations AIDS 2003, 17:1925-1932 12960825
12. Walsh JC Pozniak AL Nelson MR Mandalia S Gazzard BG Virologic rebound on HAART in the context of low treatment adherence is associated with a low prevalence of antiretroviral drug resistance J Acquir Immune Defic Syndr 2002, 30:278-287 12131564
13. Bangsberg DR Porco TC Kagay C Charlebois ED Deeks SG Guzman D Clark R Moss A Modeling the HIV protease inhibitor adherence-resistance curve by use of empirically derived estimates J Infect Dis 2004, 190:162-165 15195256
14. Bangsberg DR Deeks SG Is average adherence to HIV antiretroviral therapy enough? J Gen Intern Med 2002, 17(10):812-813 1495121 12390559
15. Moore DM Hogg RS Yip B Wood E Tyndall M Braitstein P Montaner JS Discordant immunologic and virologic responses to highly active antiretroviral therapy are associated with increased mortality and poor adherence to therapy J Acquir Immune Defic Syndr 2005, 40:288-293 16249702
16. Charalambous S Innes C Muirhead D Kumaranayake L Fielding K Pemba L Hamilton R Grant A Churchyard GJ Evaluation of a workplace HIV treatment programme in South Africa AIDS 2007, 21(Suppl 3):S73-78 17666964
17. Puccio JA Belzer M Olson J Martinez M Salata C Tucker D Tanaka D The use of cell phone reminder calls for assisting HIV-infected adolescents and young adults to adhere to highly active antiretroviral therapy: A pilot study AIDS Patient Care STDS 2006, 20:438-444 16789857
18. Johnson MO Chesney MA Goldstein RB Remien RH Catz S Gore-Felton C Charlebois E Morin SF National Institute of Mental Health Healthy Living Project Team Positive provider interactions, adherence self-efficacy, and adherence to antiretroviral medications among HIV-infected adults: A mediation model AIDS Patient Care STDS 2006, 20:258-268 2432422 16623624
19. Molassiotis A Morris K Trueman I The importance of the patient-clinician relationship in adherence to antiretroviral medication Int J Nurs Pract 2007, 13:370-376 18021166
20. Lattuada E Lanzafame M Gottardi M Corsini F Concia E Vento S Initial hospitalization and adherence to highly active antiretroviral therapy Clin Infect Dis 2008, 46:957-958 18288910
21. Johnson MO Charlebois E Morin SF Remien RH Chesney MA National Institute of Mental Health Healthy Living Project Team Effects of a behavioral intervention on antiretroviral medication adherence among people living with HIV: The healthy living project randomized controlled study J Acquir Immune Defic Syndr 2007, 46:574-580 2442469 18193499
22. Kalichman SC Cherry J Cain D Nurse-delivered antiretroviral treatment adherence intervention for people with low literacy skills and living with HIV/AIDS J Assoc Nurses AIDS Care 2005, 16;3-15 16433105
23. Simoni JM Pearson CR Pantalone DW Marks G Crepaz N Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load. A meta-analytic review of randomized controlled trials J Acquir Immune Defic Syndr 2006, 43(Suppl 1):S23-35 17133201
24. Munro S Lewin S Swart T Volmink J A review of health behaviour theories: how useful are these for developing interventions to promote long-term medication adherence for TB and HIV/AIDS? BMC Public Health 2007, 7(147 ):104 -19 1925084 17561997
25. Strathdee SA Patterson TL Behavioral interventions for HIV-positive and HCV-positive drug users AIDS Behav 2006, 10:115-130 16463006
26. Chesney MA The elusive gold standard. Future perspectives for HIV adherence assessment and intervention J Acquir Immune Defic Syndr 2006, 43(Suppl 1):S149-155 17133199
27. Rakhmanina NY Anker van den JN Soldin SJ Therapeutic drug monitoring of antiretroviral therapy AIDS Patient Care STDS 2004, 18:7-14 15006189
28. Podsadecki TJ Vrijens BC Tousset EP Rode RA Hanna GJ Decreased adherence to antiretroviral therapy observed prior to transient human immunodeficiency virus type 1 viremia J Infect Dis 2007, 196:1773-1778 18190257
29. Lazo M Gange SJ Wilson TE Anastos K Ostrow DG Witt MD Jacobson LP Patterns and predictors of changes in adherence to highly active antiretroviral therapy: Longitudinal study of men and women Clin Infect Dis 2007, 45:1377-1385 17968839
30. Barfod TS Sorensen HT Nielsen H Rodkjaer L Obel N 'Simply forgot' is the most frequently stated reason for missed doses of HAART irrespective of degree of adherence HIV Med 2006, 7:285-290 16945072
31. Bangsberg DR Hecht FM Charlebois ED Zolopa AR Holodniy M Sheiner L Bamberger JD Chesney MA Moss A Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population AIDS 2000, 14:357-366 10770537
32. Llabre MM Weaver KE Duran RE Antoni MH McPherson-Baker S Schneiderman N A measurement model of medication adherence to highly active antiretroviral therapy and its relation to viral load in HIV-positive adults AIDS Patient Care STDS 2006, 20:701-711 17052140
33. Nicca D Moody K Elzi L Spirig R Comprehensive clinical adherence interventions to enable antiretroviral therapy: A case report J Assoc Nurses AIDS Care 2007, 18:44-53 17991598
34. Kalichman SC Cain D Cherry C Kalichman M Pope H Pillboxes and antiretroviral adherence: Prevalence of use, perceived benefits, and implications for electronic medication monitoring devices AIDS Patient Care STDS 2005, 19:833-839 16375615
35. Bouhnik AD Chesney M Carrieri P Gallais H Moreau J Moatti JP Obadia Y Spire B MANIF 2000 Study Group Nonadherence among HIV-infected injecting drug users: The impact of social instability J Acquir Immune Defic Syndr 2002, 31(Suppl 3): 149-153 12562040
36. Oyugi JH Byakika-Tusiime J Charlebois ED Kityo C Mugerwa R Mugyenyi P Bangsberg DR Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting J Acquir Immune Defic Syndr 2004, 36:1100-1102 15247564
37. Samet JH Sullivan LM Traphagen ET Ickovics JR Measuring Adherence Among HIV-Infected Persons: Is MEMS Consummate Technology? AIDS and Behavior 2001, 5:21-30
38. Altmann A Rosen-Zvi M Prosperi M Aharoni E Neuvirth H Schulter E Buch J Struck D Peres Y Incardona F Sonnerborg A Kaiser R Zazzi M Lengauer T Comparison of classifier fusion methods for predicting response to anti HIV-1 therapy PLoS ONE 2008, 3:e3470 2565127 18941628
39. EuResist prediction system http://engine.euresist.org
40. Tatusova TA Madden TL BLAST 2 Sequences, a new tool for comparing protein and nucleotide sequences FEMS Microbiol Lett 1999, 174:247-250 10339815
41. Pearson WR Rapid and sensitive sequence comparison with FASTP and FASTA Methods Enzymol 1990, 183:63-98 2156132